Video Latest - ecancer

ASCO: Impact of common antidepressants on tamoxifen effectiveness

Dr. Vincent O. Dezentjé - Leiden University Medical Center, Leiden, The Netherlands

18 Jun 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute

14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research

14 May 2009

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco

14 May 2009

AACR 2009: Caucasian-american and african-american breast cancer risk factors

Prof Yong Cui - Department of Internal Medicine, Meharry Medical College, USA

7 May 2009

Two new methods in digital mammography

Dr Maria Pizzamiglio - Deputy Director, Breast Radiology Unit, European Institute of Oncology, Milan

31 Mar 2009

Europa Donna and breast screening

Dr Giovanna Gatti - Breast Surgeon and President of the Italian Branch of Europa Donna

31 Mar 2009

Bacteria as agents to initiate potent anti-tumour activity

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan

31 Mar 2009

Reductions in breast density predict potential benefit of tamoxifen

Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London

11 Mar 2009

BIG 1-98: Letrozole vs tamoxifen

Dr Alan Coates - School of Public Health, University of Sydney

11 Mar 2009

Continuing adjuvant tamoxifen leads to higher quality of life

Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan

11 Mar 2009

New biomarker predicts anthracycline response

Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University

11 Mar 2009

Video